Penn State Health Milton S. Hershey Medical Center is a 628-bed non-profit, tertiary, research and academic medical center located in Hershey, Pennsylvania, servicing the Central Pennsylvania area. MSHMC is the region's only university-level academic medical center.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Milton S. Hershey Medical Center
226
National Cancer Institute (NCI)
116
Gynecologic Oncology Group
40
Radiation Therapy Oncology Group
22
Penn State University
21
National Institute of Allergy and Infectious Diseases (NIAID)
20
Children's Oncology Group
19
SWOG Cancer Research Network
19
Pfizer
18
ECOG-ACRIN Cancer Research Group
16
Celgene
13
Clinical Trials at Penn State Milton S. Hershey Medical Center
During the past decade, Penn State Milton S. Hershey Medical Center conducted 467 clinical trials. In the 10-year time frame, 467 clinical trials started and 337 clinical trials were completed, i.e. on
average, 72.2% percent of trials that started reached the finish line to date. In the past 5 years, 145 clinical trials started and 140 clinical trials were completed. i.e. 96.6%
of trials that started reached the finish line.
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease
1998-11-01
Completed
390
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Penn State Milton S. Hershey Medical Center" #1 sponsor was "Milton S. Hershey Medical Center" with 226 trials, followed by "National Cancer Institute (NCI)" with 116 trials
sponsored, "Gynecologic Oncology Group" with 40 trials sponsored, "Radiation Therapy Oncology Group" with 22 trials sponsored and "Penn State University"
with 22 trials sponsored. Other sponsors include 688 different institutions and
companies that sponsored additional 337 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Penn State Milton S. Hershey Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 163 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Milton S. Hershey Medical Center" with 20 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 19 trials as a collaborator and "National Institutes of Health (NIH)" with 19 trials as a collaborator. Other collaborators include 568 different institutions and companies that were
collaborators in the rest 339 trials.
Clinical Trials Conditions at Penn State Milton S. Hershey Medical Center
According to Clinical.Site data, the most researched conditions in "Penn State Milton S. Hershey Medical Center" are
"Cystic Fibrosis" (30 trials), "HIV Infections" (28 trials), "Heart Failure" (25 trials), "Breast Cancer" (22 trials) and "Ovarian Cancer" (20 trials). Many other conditions were trialed in "Penn State Milton S. Hershey Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Penn State Milton S. Hershey Medical Center
Most popular intervention types in "Penn State Milton S. Hershey Medical Center" are "Drug" (716 trials), "Other" (250 trials), "Device" (126 trials), "Biological" (123 trials) and "Procedure" (113 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (125 trials), "Laboratory Biomarker Analysis" (91 trials), "Quality-of-Life Assessment" (46 trials), "Paclitaxel" (34 trials) and "Carboplatin" (29 trials). Other intervention names were less common.
Clinical Trials Genders at Penn State Milton S. Hershey Medical Center
The vast majority of trials in "Penn State Milton S. Hershey Medical Center" are
957 trials for "All" genders, 128 trials for "Female" genders and 33 trials for "Male" genders.
Clinical Trials Status at Penn State Milton S. Hershey Medical Center
Currently, there are 304 active trials in "Penn State Milton S. Hershey Medical Center".
3 are not yet recruiting,
142 are recruiting,
149 are Active, not recruiting,
and 10 are Enrolling by invitation.
In total, there were 624 completed trials in Penn State Milton S. Hershey Medical Center,
4 suspended trials,
and 138 terminated clinical trials to date.
Out of the total trials that were conducted in Penn State Milton S. Hershey Medical Center, 95 "Phase 1"
clinical trials were conducted, 317 "Phase 2" clinical
trials and 352 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 59 trials, and there were
also 215 trials that are defined as “Not Applicable".
Departments of Penn State Milton S. Hershey Medical Center
Penn State Milton S. Hershey Medical Center has several departments that took part in Clinical trials: "Penn State Children's Hospital" - 172 trials, "Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases" - 6 trials, "Penn State Hershey Medical Center Department of Dermatology" - 4 trials, "Penn State Hershey Neurology" - 2 trials